Skip to content
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Shopping cart$0.00 0
Login
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Dizal
  • Approved News

Dizal: ZEGFROVY®Sunvozertinib, developed by Dizal Pharmaceutical, is poised to reshape the global first-line treatment landscape for EGFR exon20ins NSCLC with its pivotal Phase III study.

Sifrol (Pramipexole Dihydrochloride Sustained-Release Tablets)
  • Drug news

How much does Sifrol (Pramipexole Dihydrochloride Sustained-Release Tablets) Cost& price without insurance in China?

  • Approved News

Akeso: Ivonescimab + Chemotherapy Beats PD-1 + Chemotherapy, OS Significantly Positive

bristol-myers-squibb
  • Approved News

Bristol Myers Squibb: Camzyos mavacamten supplemental New Drug Application (sNDA) accepted by the U.S. FDA.

Amgen
  • Approved News

Amgen:IMDELLTRA®Tarlatamabwas approved in the European Union.

Cymbalta (Duloxetine Hydrochloride Enteric Capsules)
  • Drug news

How much does Cymbalta (Duloxetine Hydrochloride Enteric Capsules) Cost& price without insurance in China?

  • Approved News

Haisco:CYPSEDO® Ciprofol received a US FDA marketing application.

Legend
  • Approved News

Legend Biotech:LB2501 clinical data were disclosed.

Legend
  • Approved News

Legend Biotech:Carvykti ciltacabtagene autoleucel is the best-selling cell therapy product in the world.

Kisunla (Donanemab Injection)
  • Drug news

How much does Kisunla (Donanemab Injection) Cost& price without insurance in China?

  • Drug development

Henlius:Pimurutamab Completed First Patient Dosing in China

Biogen
  • Approved News

Biogen:BIIB122 failed in Phase IIb clinical trial.

Prev
1 … 11 12 13 14 15 16 17 … 26
Next
Contact us

WeChat: +86 139 2425 9988
WhatsApp : +852 9100 6363
Email: info@xpharma.com.cn

Rm F2-48, 6/F, No. 47 Guomao Road, Hainan, China

Useful Links
  • Medicines
  • Chinese innovative drug
  • Medicines Approved News
  • Drug Development News
  • Drug News
  • Privacy Policy
Email Newsletter

Subscribe to our newsletter and get 10% off your first purchase

Copyright © {2026} -Xpharma China